We are live on ! Find out more
SCM

Smead Capital Management Portfolio holdings

AUM $4.6B
1-Year Est. Return 27.56%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+27.56%
3 Year Est. Return
+64.97%
5 Year Est. Return
+125.46%
10 Year Est. Return
+462.58%
AUM
$830M
AUM Growth
+$104M
Cap. Flow
+$81.9M
Cap. Flow %
9.86%
Top 10 Hldgs %
52.31%
Holding
30
New
1
Increased
24
Reduced
2
Closed
2

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$17.9M
2
BMY icon
Bristol-Myers Squibb
BMY
+$10.3M
3
WBA
Walgreens Boots Alliance
WBA
+$2.16M
4
DIS icon
Walt Disney
DIS
+$1.06M

Sector Composition

Rank Sector Weight
1 Healthcare 32.34%
2 Financials 29.45%
3 Consumer Discretionary 20.79%
4 Communication Services 10.86%
5 Technology 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGNA
1
DELISTED
TEGNA Inc
TGNA
$53.1M 6.4%
3,679,454
+459,102
+14% +$6.83M
EBAY icon
2
eBay
EBAY
$48.6B
$47.3M 5.7%
2,036,617
+257,834
+14% +$5.99M
CAB
3
DELISTED
Cabela's Inc
CAB
$46.6M 5.62%
711,992
+88,665
+14% +$5.96M
BAC icon
4
Bank of America
BAC
$435B
$43.2M 5.2%
2,510,640
+236,851
+10% +$3.98M
MRK icon
5
Merck
MRK
$324B
$42.9M 5.17%
792,017
+97,493
+14% +$5.05M
WBA
6
DELISTED
Walgreens Boots Alliance
WBA
$42.5M 5.12%
643,334
-34,339
-5% -$2.16M
AMGN icon
7
Amgen
AMGN
$203B
$42.2M 5.09%
342,235
+42,696
+14% +$5.18M
AFL icon
8
Aflac
AFL
$63.9B
$38.9M 4.68%
1,233,382
+156,486
+15% +$4.97M
WFC icon
9
Wells Fargo
WFC
$261B
$38.9M 4.68%
781,355
+96,769
+14% +$4.51M
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.07T
$38.5M 4.64%
308,234
+105,487
+52% +$12.3M
JPM icon
11
JPMorgan Chase
JPM
$939B
$38.3M 4.62%
631,186
+78,779
+14% +$4.55M
DIS icon
12
Walt Disney
DIS
$165B
$37M 4.46%
462,128
-13,681
-3% -$1.06M
JWN
13
DELISTED
Nordstrom
JWN
$30.5M 3.67%
488,300
+60,233
+14% +$3.63M
CMCSK
14
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$30.1M 3.62%
616,399
+76,447
+14% +$3.73M
BEN icon
15
Franklin Resources
BEN
$16.9B
$28M 3.38%
517,055
+63,719
+14% +$3.43M
PFE icon
16
Pfizer
PFE
$140B
$27.6M 3.33%
907,323
+112,502
+14% +$3.35M
HRB icon
17
H&R Block
HRB
$5.18B
$26M 3.13%
861,368
+107,040
+14% +$3.21M
ACN icon
18
Accenture
ACN
$89.9B
$24.4M 2.94%
306,529
+37,738
+14% +$3.1M
HD icon
19
Home Depot
HD
$332B
$23.7M 2.86%
299,518
+37,130
+14% +$2.95M
MDT icon
20
Medtronic
MDT
$107B
$20.9M 2.52%
340,241
+42,126
+14% +$2.45M
NVR icon
21
NVR
NVR
$17.2B
$19.4M 2.33%
16,892
+2,087
+14% +$2.35M
CB
22
DELISTED
CHUBB CORPORATION
CB
$17.5M 2.1%
+195,561
New +$17.1M
ABBV icon
23
AbbVie
ABBV
$458B
$16.7M 2.01%
324,770
+40,140
+14% +$2.03M
JNJ icon
24
Johnson & Johnson
JNJ
$635B
$16.4M 1.98%
167,189
+20,731
+14% +$1.92M
MCD icon
25
McDonald's
MCD
$188B
$14.2M 1.71%
144,744
+17,928
+14% +$1.71M

Similar funds

Smead Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Smead Capital Management held 30 positions worth $830M, up 14% from $726M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Smead Capital Management deployed $81.9M of net new capital in Q1 2014, opening 1 new position and adding to 24 existing holdings. Its largest new stake was CHUBB CORPORATION: 195,561 shares worth $17.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $2.16M trimmed.

  • Smead Capital Management's largest Q1 2014 buy was CHUBB CORPORATION: 195,561 shares worth $17.5M.
  • Smead Capital Management added most to Berkshire Hathaway Class B in Q1 2014, an estimated $12.3M increase.
  • Smead Capital Management's biggest Q1 2014 reduction was Walgreens Boots Alliance, cutting an estimated $2.16M.
  • Smead Capital Management fully exited Viatris in Q1 2014, selling an estimated $17.9M.
  • Smead Capital Management's ten largest holdings make up 52% of its $830M portfolio in Q1 2014.
  • Smead Capital Management opened 1 new position and closed 2 in Q1 2014.
  • Smead Capital Management's portfolio value rose 14% quarter-over-quarter to $830M.

Based on Smead Capital Management's 13F filing for Q1 2014, filed 8 May 2014.